{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:58:55Z","timestamp":1793383135176,"version":"4.5.0"},"reference-count":205,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T00:00:00Z","timestamp":1607385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>In the setting of myocardial infarction (MI), ischemia reperfusion injury (IRI) occurs due to occlusion (ischemia) and subsequent re-establishment of blood flow (reperfusion) of a coronary artery. A similar phenomenon is observed in heart transplantation (HTx) when, after cold storage, the donor heart is connected to the recipient\u2019s circulation. Although reperfusion is essential for the survival of cardiomyocytes, it paradoxically leads to additional myocardial damage in experimental MI and HTx models. Damage (or danger)-associated molecular patterns (DAMPs) are endogenous molecules released after cellular damage or stress such as myocardial IRI. DAMPs activate pattern recognition receptors (PRRs), and set in motion a complex signaling cascade resulting in the release of cytokines and a profound inflammatory reaction. This inflammatory response is thought to function as a double-edged sword. Although it enables removal of cell debris and promotes wound healing, DAMP mediated signalling can also exacerbate the inflammatory state in a disproportional matter, thereby leading to additional tissue damage. Upon MI, this leads to expansion of the infarcted area and deterioration of cardiac function in preclinical models. Eventually this culminates in adverse myocardial remodeling; a process that leads to increased myocardial fibrosis, gradual further loss of cardiomyocytes, left ventricular dilation and heart failure. Upon HTx, DAMPs aggravate ischemic damage, which results in more pronounced reperfusion injury that impacts cardiac function and increases the occurrence of primary graft dysfunction and graft rejection via cytokine release, cardiac edema, enhanced myocardial\/endothelial damage and allograft fibrosis.\u00a0Therapies targeting DAMPs or PRRs have predominantly been investigated in experimental models and are potentially cardioprotective. To date, however, none of these interventions have reached the clinical arena. In this review we summarize the current evidence of involvement of DAMPs and PRRs in the inflammatory response after MI and HTx. Furthermore, we will discuss various current therapeutic approaches targeting this complex interplay and provide possible reasons why clinical translation still fails.<\/jats:p>","DOI":"10.3389\/fimmu.2020.599511","type":"journal-article","created":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T00:32:16Z","timestamp":1607387536000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":179,"title":["Damage-Associated Molecular Patterns in Myocardial Infarction and Heart Transplantation: The Road to Translational Success"],"prefix":"10.3389","volume":"11","author":[{"given":"Max J. M.","family":"Silvis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma E.","family":"Kaffka genaamd Dengler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence A.","family":"Odille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mudit","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels P.","family":"van der Kaaij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter A.","family":"Doevendans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost P. G.","family":"Sluijter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique P. V.","family":"de Kleijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia C. A.","family":"de Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardus P. J.","family":"van Hout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx393","article-title":"ESC Guidelines for the management of acute myocardial infarction inpatients presenting with ST-segment elevation","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2011.12.075","article-title":"Impact of warm ischemia time on survival after hearttransplantation","volume":"44","author":"Marasco","year":"2012","journal-title":"Transplant Proc"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2011.01.721","article-title":"RADIAL: A novel primary graft failure risk score in hearttransplantation","volume":"30","author":"Segovia","year":"2011","journal-title":"J\u00a0Hear Lung Transplant"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2017.07.019","article-title":"The Registry of the International Society for Heart and LungTransplantation: Thirty-fourth Adult Heart Transplantation Report\u20142017; Focus Theme: Allograftischemic time","volume":"36","author":"Lund","year":"2017","journal-title":"J Hear Lung Transplant"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1056\/NEJMc072913","article-title":"Hausenloy PD. Myocardial reperfusion injury [14]","volume":"357","author":"Derek","year":"2007","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/imr.12577","article-title":"Alarmins and immunity","volume":"280","author":"Yang","year":"2017","journal-title":"Immunological Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1172\/JCI62874","article-title":"Myocardial ischemia-reperfusion injury: A neglected therapeutictarget","volume":"123","author":"Hausenloy","year":"2013","journal-title":"J Clin Invest"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s40472-014-0017-6","article-title":"Ischemia\/Reperfusion Injury and its Consequences on Immunity andInflammation","volume":"1","author":"Slegtenhorst","year":"2014","journal-title":"Curr Transplant Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.02.032","article-title":"Evolving Therapies for Myocardial Ischemia\/Reperfusion Injury","volume":"65","author":"Ib\u00e1\u00f1ez","year":"2015","journal-title":"J Am Coll Cardiol [Internet]"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M306793200","article-title":"Involvement of Toll-like Receptors 2 and 4 in Cellular Activation byHigh Mobility Group Box 1 Protein","volume":"279","author":"Park","year":"2004","journal-title":"J Biol Chem"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.769331","article-title":"High-mobility group box-1 in ischemia-reperfusion injury of theheart","volume":"117","author":"Andrassy","year":"2008","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2018.09.043","article-title":"The myocardial infarct-exacerbating effect of cell-free DNA ismediated by the high-mobility group box 1\u2013receptor for advanced glycation endproducts\u2013Toll-like receptor 9 pathway","volume":"157","author":"Tian","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B13","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41419-019-1718-7","article-title":"TLR9 is essential for HMGB1-mediated post-myocardial infarctiontissue repair through affecting apoptosis, cardiac healing, and angiogenesis","volume":"10","author":"Liu","year":"2019","journal-title":"Cell Death Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.00037","article-title":"Receptor for advanced glycation end products (Rage) and mechanismsand therapeutic opportunities in diabetes and cardiovascular disease: Insights from human subjectsand animal models","volume":"10","author":"Ega\u00f1a-Gorro\u00f1o","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.757443","article-title":"Modulated inflammation by injection of high-mobility group box 1recovers post-infarction chronically failing heart","volume":"118","author":"Takahashi","year":"2008","journal-title":"Circulation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/cvr\/cvn163","article-title":"High-mobility group box 1 restores cardiac function after myocardialinfarction in transgenic mice","volume":"80","author":"Kitahara","year":"2008","journal-title":"Cardiovasc Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1253\/circj.72.1178","article-title":"Effects of HMGB1 on ischemia-reperfusion injury in the ratheart","volume":"72","author":"Oozawa","year":"2008","journal-title":"Circ J"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvn291","article-title":"Role of high-mobility group box 1 protein in post-infarction healingprocess and left ventricular remodelling","volume":"81","author":"Kohno","year":"2009","journal-title":"Cardiovasc Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181a36e5e","article-title":"Mechanisms of toll-like receptor 4 (TLR4)-mediated inflammationafter cold ischemia\/reperfusion in the heart","volume":"87","author":"Kaczorowski","year":"2009","journal-title":"Transplantation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/labinvest.2010.141","article-title":"High-mobility group box 1 promotes early acute allograft rejectionby enhancing IL-6-dependent Th17 alloreactive response","volume":"91","author":"Duan","year":"2011","journal-title":"Lab Invest"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12781","article-title":"HMGB1 is involved in chronic rejection of cardiac allograft viapromoting inflammatory-like mDCs","volume":"14","author":"Zou","year":"2014","journal-title":"Am J Transplant"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.109.209643","article-title":"Extracellular heat shock protein 60, cardiac myocytes, andapoptosis","volume":"105","author":"Kim","year":"2009","journal-title":"Circ Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2006.02.024","article-title":"Human heat shock protein 60 stimulates vascular smooth muscle cellproliferation through Toll-like receptors 2 and 4","volume":"8","author":"de Graaf","year":"2006","journal-title":"Microbes Infect"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(99)00012-7","article-title":"Myocardial injury leads to a release of heat shock protein (hsp) 60 and a suppression of the anti-hsp65 immune response","volume":"42","author":"Schett","year":"1999","journal-title":"Cardiovasc Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/cvr\/cvt047","article-title":"Extracellular HSP60 induces inflammation through activating andup-regulating TLRs in cardiomyocytes","volume":"98","author":"Tian","year":"2013","journal-title":"Cardiovasc Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.246124","article-title":"Myocardial ischemia activates an injurious innate immune signalingvia cardiac heat shock protein 60 and toll-like receptor 4","volume":"286","author":"Li","year":"2011","journal-title":"J BiolChem"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2009.04.002","article-title":"Myocardial heat shock protein 60 expression is upregulated followingacute cardiac rejection","volume":"21","author":"Sarri","year":"2009","journal-title":"Transpl Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0014-2999(01)01552-7","article-title":"Oral bimoclomol elevates heat shock protein 70 and reducesmyocardial infarct size in rats","volume":"435","author":"Lubbers","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/74697","article-title":"HSP70 stimulates cytokine production through a CD 14-dependantpathway, demonstrating its dual role as a chaperone and cytokine","volume":"6","author":"Asea","year":"2000","journal-title":"NatMed"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.10.044","article-title":"Heat Shock Protein 70 as a Biomarker of Clinical Outcomes AfterSTEMI","volume":"75","author":"Bochaton","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.suppl_3.III-302","article-title":"Gene therapy for myocardial protection: Transfection of donor heartswith heat shock protein 70 gene protects cardiac function against ischemia-reperfusioninjury","volume":"102","author":"Jayakumar","year":"2000","journal-title":"Circulation"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1161\/hc37t1.094932","article-title":"Heat shock protein 70 gene transfection protects mitochondrial and ventricular function against ischemia-reperfusion injury","author":"Jayakumar","year":"2001","journal-title":"Circulation"},{"key":"B33","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/00007890-199803270-00006","article-title":"Possible relationship between heat shock protein 70, cardiachemodynamics, and survival in the early period after heart transplantation","volume":"65","author":"Baba","year":"1998","journal-title":"Transplantation"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M100099200","article-title":"The Extra Domain A of Fibronectin Activates Toll-like Receptor4","volume":"276","author":"Okamura","year":"2001","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.110.224428","article-title":"Lack of fibronectin-EDA promotes survival and prevents adverseremodeling and heart function deterioration after myocardial infarction","volume":"108","author":"Arslan","year":"2011","journal-title":"Circ Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.38.suppl_1.374","article-title":"Deletion of Extra Domain A of Fibronectin Reduces Acute MyocardialIschaemia\/Reperfusion Injury in Hyperlipidaemic Mice by Limiting Thrombo-Inflammation","author":"Chorawala","year":"2018","journal-title":"Thromb Haemost"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/path.3010","article-title":"Recipient-derived EDA fibronectin promotes cardiac allograftfibrosis","volume":"226","author":"Booth","year":"2012","journal-title":"J Pathol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.healun.2010.08.015","article-title":"Expression of extra domain A containing fibronectin in chroniccardiac allograft rejection","volume":"30","author":"Franz","year":"2011","journal-title":"J Hear Lung Transplant"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s10735-014-9573-4","article-title":"De novo expression of fetal ED-A+ fibronectin and B+ tenascin-Csplicing variants in human cardiac allografts: Potential impact for targeted therapy ofrejection","volume":"45","author":"Franz","year":"2014","journal-title":"J Mol Histol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.2.1272","article-title":"Hyaluronan Fragments Act as an Endogenous Danger Signal by EngagingTLR2","volume":"177","author":"Scheibner","year":"2006","journal-title":"J Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/nm1315","article-title":"Regulation of lung injury and repair by Toll-like receptors andhyaluronan","volume":"11","author":"Jiang","year":"2005","journal-title":"Nat Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.313285","article-title":"Cardiac hyaluronan synthesis is critically involved in the cardiacmacrophage response and promotes healing after ischemia reperfusion injury","volume":"124","author":"Petz","year":"2019","journal-title":"Circ Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.7150\/thno.31073","article-title":"Hyaluronic acid oligosaccharides improve myocardial functionreconstruction and angiogenesis against myocardial infarction by regulation ofmacrophages","volume":"9","author":"Wang","year":"2019","journal-title":"Theranostics"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1172\/JCI115475","article-title":"Accumulation of hyaluronan and tissue edema in experimentalmyocardial infarction","volume":"88","author":"Waldenstr\u00f6m","year":"1991","journal-title":"J Clin Invest"},{"key":"B45","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1620\/tjem.248.99","article-title":"Hyaluronan as a promising biomarker for myocardialdamage","volume":"248","author":"Savas","year":"2019","journal-title":"Tohoku J Exp Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1172\/JCI114490","article-title":"Accumulation of hyaluronan (hyaluronic acid) in myocardialinterstitial tissue parallels development of transplantation edema in heart allografts inrats","volume":"85","author":"H\u00e4llgren","year":"1990","journal-title":"J Clin Invest"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2010.04.012","article-title":"Increased Th17 rather than Th1 alloimmune response is associatedwith cardiac allograft vasculopathy after hypothermic preservation in the rat","volume":"29","author":"Syrj\u00e4l\u00e4","year":"2010","journal-title":"J\u00a0Hear Lung Transplant"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.161293498","article-title":"Human TLR9 confers responsiveness to bacterial DNA viaspecies-specific CpG motif recognition","volume":"98","author":"Bauer","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201949799","article-title":"Mitochondrial DNA in inflammation and immunity","volume":"21","author":"Riley","year":"2020","journal-title":"EMBO Rep"},{"key":"B50","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41586-018-0372-z","article-title":"New mitochondrial DNA synthesis enables NLRP3 inflammasomeactivation","volume":"560","author":"Zhong","year":"2018","journal-title":"Nature"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2012.04.047","article-title":"Increased circulating mitochondrial DNA after myocardialinfarction","volume":"158","author":"Bliksoen","year":"2012","journal-title":"Int J Cardiol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-011-1221-7","article-title":"Nuclear-mitochondrial cross-talk in global myocardial ischemia. Atime-course analysis","volume":"364","author":"Mar\u00edn-Garc\u00eda","year":"2012","journal-title":"Mol Cell Biochem"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.7515","article-title":"Mitochondrial DNA-induced inflammatory damage contributes tomyocardial ischemia reperfusion injury in rats: Cardioprotective role ofepigallocatechin","volume":"16","author":"Qin","year":"2017","journal-title":"Mol Med Rep"},{"key":"B54","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1159\/000494034","article-title":"Extracellular RNA Sensing by Pattern RecognitionReceptors","volume":"10","author":"Tatematsu","year":"2018","journal-title":"J Innate Immun"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.661835","article-title":"Cardiac RNA induces inflammatory responses in cardiomyocytes andimmune cells via Toll-like receptor 7 signaling","volume":"290","author":"Feng","year":"2015","journal-title":"J Biol Chem"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/JAHA.113.000683","article-title":"Role of extracellular RNA and TLR3-Trif signaling in myocardialischemia-reperfusion injury","volume":"3","author":"Chen","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.7150\/thno.17366","article-title":"Theranostic nucleic acid binding nanoprobe exerts anti-inflammatoryand cytoprotective effects in ischemic injury","volume":"7","author":"Chen","year":"2017","journal-title":"Theranostics"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1160\/th14-08-0703","article-title":"RNase1 prevents the damaging interplay between extracellular RNA andtumour necrosis factor-\u03b1 in cardiac ischaemia\/reperfusion injury","volume":"112","author":"Cabrera-Fuentes","year":"2014","journal-title":"Thromb Haemost"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0800861","article-title":"Cutting Edge: Cardiac Myosin Activates Innate Immune Responsesthrough TLRs","volume":"183","author":"Zhang","year":"2009","journal-title":"J Immunol"},{"key":"B60","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.162.11.6836","article-title":"De novo autoimmunity to cardiac myosin after heart transplantationand its contribution to the rejection process","volume":"162","author":"Fedoseyeva","year":"1999","journal-title":"J Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(99)00632-6","article-title":"Allo- and autoantibodies in human cardiac allograftrecipients","volume":"31","author":"Morgun","year":"1999","journal-title":"Transplant Proc"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.3.1168","article-title":"Modulation of Tissue-Specific Immune Response to Cardiac Myosin CanProlong Survival of Allogeneic Heart Transplants","volume":"169","author":"Fedoseyeva","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(03)00114-1","article-title":"Pre- and post-transplant anti-myosin and anti-heat shock proteinantibodies and cardiac transplant outcome","volume":"23","author":"Morgun","year":"2004","journal-title":"J Hear Lung Transplant"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation totherapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.13079","article-title":"P2X7 receptor in cardiovascular disease: The heartside","volume":"46","author":"Guerra Martinez","year":"2019","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1172\/JCI94524","article-title":"P2X7R mutation disrupts the NLRP3-mediated Th program and predictspoor cardiac allograft outcomes","volume":"128","author":"D\u2019Addio","year":"2018","journal-title":"J Clin Invest"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/1755-5922.12245","article-title":"Targeted P2X7R shRNA delivery attenuates sympathetic nerve sproutingand ameliorates cardiac dysfunction in rats with myocardial infarction","volume":"35","author":"Gao","year":"2017","journal-title":"Cardiovasc Ther"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1108586108","article-title":"The inflammasome promotes adverse cardiac remodeling following acutemyocardial infarction in the mouse","volume":"108","author":"Mezzaroma","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B69","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s00395-012-0250-z","article-title":"S100A8\/A9 aggravates post-ischemic heart failure through activationof RAGE-dependent NF-\u03baB signaling","volume":"107","author":"Volz","year":"2012","journal-title":"Basic Res Cardiol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nrcardio.2011.38","article-title":"Innate immune signaling in cardiac ischemia","volume":"8","author":"Arslan","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.2016.1088005","article-title":"Targeting danger-associated molecular patterns after myocardialinfarction","volume":"20","author":"Van Hout","year":"2016","journal-title":"Expert Opin Ther Targets"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-019-09794-1","article-title":"Primary graft dysfunction after heart transplantation: a thornamongst the roses","volume":"24","author":"Singh","year":"2019","journal-title":"Heart Failure Rev"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-019-0216-2","article-title":"The innate immune response to allotransplants: mechanisms andtherapeutic potentials","volume":"16","author":"Ochando","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1172\/JCI90594","article-title":"Danger signals in regulating the immune response to solid organtransplantation","volume":"127","author":"Todd","year":"2017","journal-title":"J Clin Invest"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13963","article-title":"Transplantation and Damage-Associated Molecular Patterns(DAMPs)","volume":"16","author":"Land","year":"2016","journal-title":"Am J Transplant"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2016.41","article-title":"Role of TLRs and DAMPs in allograft inflammation and transplantoutcomes","volume":"12","author":"Braza","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2012.112","article-title":"Glycyrrhizin protects rat heart against ischemia-reperfusion injurythrough blockade of HMGB1-dependent phospho-JNK\/Bax pathway","volume":"33","author":"Zhai","year":"2012","journal-title":"Acta Pharmacol Sin"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.4617","article-title":"Protective effect of glycyrrhizin on myocardial ischemia\/reperfusioninjury-induced oxidative stress, inducible nitric oxide synthase and inflammatory reactions throughhigh-mobility group box 1 and mitogen-activated protein kinase expression","volume":"14","author":"Cai","year":"2017","journal-title":"Exp Ther Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1536\/ihj.19-321","article-title":"Reduction of cold ischemic injury with the addition of compoundglycyrrhizin in HTK solution in a mouse heart transplantation model","volume":"61","author":"Wu","year":"2020","journal-title":"Int Heart J"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e318293b7e1","article-title":"Hmgb1-TLR4-IL-23-IL-17A axis promote ischemia-reperfusion injury ina cardiac transplantation model","volume":"95","author":"Zhu","year":"2013","journal-title":"Transplantation"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1161\/hc3901.095771","article-title":"Single oral dose of geranylgeranylacetone induces heat-shock protein72 and renders protection against ischemia\/reperfusion injury in rat heart","volume":"104","author":"Ooie","year":"2001","journal-title":"Circulation"},{"key":"B82","article-title":"Geranylgeranylacetone attenuates myocardium ischemic\/reperfusioninjury through HSP70 and Akt\/GSK-3\u03b2\/eNOS pathway","volume":"9","author":"Zhou","year":"2017","journal-title":"Am J Transl Res"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2019.07.010","article-title":"Oral geranylgeranylacetone treatment increases heat shock proteinexpression in human atrial tissue","volume":"17","author":"van Marion","year":"2020","journal-title":"Hear Rhythm"},{"key":"B84","doi-asserted-by":"publisher","first-page":"H311","DOI":"10.1152\/ajpheart.00515.2017","article-title":"A novel mtDNA repair fusion protein attenuates maladaptiveremodeling and preserves cardiac function in heart failure","volume":"314","author":"Bradley","year":"2018","journal-title":"Am J Physiol -Hear Circ Physiol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.000901","article-title":"Inhibition of toll-like receptor 4 with eritoran attenuatesmyocardial ischemia-reperfusion injury","volume":"114","author":"Shimamoto","year":"2006","journal-title":"Circulation"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2010.03.133","article-title":"Protective Effects of Toll-like Receptor 4 Inhibitor Eritoran onRenal Ischemia-Reperfusion Injury","volume":"42","author":"Liu","year":"2010","journal-title":"Transplant Proc"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.2194","article-title":"Effect of eritoran, an antagonist of MD2-TLR4, on mortality inpatients with severe sepsis: The ACCESS randomized trial","volume":"309","author":"Opal","year":"2013","journal-title":"JAMA - J Am Med Assoc"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvz066","article-title":"Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuatesmyocardial ischaemia-reperfusion injury by inhibiting monocyte-mediated inflammation inmice","volume":"115","author":"Fujiwara","year":"2019","journal-title":"Cardiovasc Res"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181e7c5c9","article-title":"A randomized, double-blind, placebo-controlled trial of TAK-242 forthe treatment of severe sepsis","volume":"38","author":"Rice","year":"2010","journal-title":"Crit Care Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.109.880187","article-title":"Myocardial ischemia\/reperfusion injury is mediated by leukocytictoll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2antibody","volume":"121","author":"Arslan","year":"2010","journal-title":"Circulation"},{"key":"B91","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1161\/CIRCINTERVENTIONS.111.967596","article-title":"Treatment with OPN-305, a humanized anti-toll-like receptor-2antibody, reduces myocardial ischemia\/reperfusion injury in pigs","volume":"5","author":"Arslan","year":"2012","journal-title":"CircCardiovasc Interv"},{"key":"B92","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1096\/fj.11-195396","article-title":"Inhibition of TLR2 promotes graft function in a murine model ofrenal transplant ischemia-reperfusion injury","volume":"26","author":"Farrar","year":"2012","journal-title":"FASEB J"},{"key":"B93","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/clpt.2013.150","article-title":"Randomized, double-blind, placebo-controlled, dose-escalating phaseI, healthy subjects study of intravenous OPN-305, a humanized anti-TLR2 antibody","volume":"94","author":"Reilly","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/5271251","article-title":"Pharmacological inhibition of NLRP3 inflammasome attenuatesmyocardial ischemia\/reperfusion injury by activation of RISK and mitochondrialpathways","volume":"2016","author":"Mastrocola","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/FJC.0000000000000247","article-title":"Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves CardiacFunction after Ischemic and Nonischemic Injury in the Mouse","volume":"66","author":"Marchetti","year":"2015","journal-title":"J Cardiovasc Pharmacol"},{"key":"B96","article-title":"No Title","volume":"20","author":"Toldo","year":"2020","journal-title":"Am J Transplant"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000000658","article-title":"The NLRP3 Inflammasome Inhibitor, OLT1177 (Dapansutrile), Reduces Infarct Size and Preserves Contractile Function After Ischemia Reperfusion Injury in the Mouse","volume":"73","author":"Toldo","year":"2019","journal-title":"J Cardiovasc Pharmacol"},{"key":"B98","unstructured":"NCT03534297Study of Dapansutrile Capsules in Heart Failure2018"},{"key":"B99","article-title":"NCT02104050","volume-title":"Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain. A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessatio","year":"2014"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw247","article-title":"The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction","volume":"38","author":"Van Hout","year":"2017","journal-title":"Eur Heart J"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-016-9518-3","article-title":"Long noncoding NONRATT021972 siRNA normalized abnormal sympatheticactivity mediated by the upregulation of P2X7 receptor in superior cervical ganglia after myocardialischemia","volume":"12","author":"Tu","year":"2016","journal-title":"Purinergic Signal"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/5381290","article-title":"Cardioprotective effects of genistin in rat myocardialischemia-reperfusion injury studies by regulation of P2X7\/NF-\u03baB pathway","volume":"2016","author":"Gu","year":"2016","journal-title":"Evidence-Based Complement Altern Med"},{"key":"B104","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1161\/CIRCULATIONAHA.112.123653","article-title":"Long-term heart transplant survival by targeting the ionotropicpurinergic receptor P2X7","volume":"127","author":"Vergani","year":"2013","journal-title":"Circulation"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-014-0527-x","article-title":"Deoxycholic acid-modified polyethylenimine based nanocarriers forRAGE siRNA therapy in acute myocardial infarction","volume":"38","author":"Ku","year":"2015","journal-title":"Arch Pharm Res"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.51.348","article-title":"BAY 11-7082, a nuclear factor-\u03baB inhibitor, reduces inflammation and apoptosis in a rat cardiac ischemia-reperfusion injury model","volume":"51","author":"Kim","year":"2010","journal-title":"Int Heart J"},{"key":"B107","doi-asserted-by":"publisher","first-page":"H2248","DOI":"10.1152\/ajpheart.00776.2007","article-title":"IKK\u03b2 inhibition attenuates myocardial injury and dysfunctionfollowing acute ischemia-reperfusion injury","volume":"293","author":"Moss","year":"2007","journal-title":"Am J Physiol - Hear Circ Physiol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2007.02.049","article-title":"Proteasome Inhibition Attenuates Infarct Size and Preserves CardiacFunction in a Murine Model of Myocardial Ischemia-Reperfusion Injury","volume":"84","author":"Stansfield","year":"2007","journal-title":"AnnThorac Surg"},{"key":"B109","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1006\/jmcc.1999.1089","article-title":"Tacrolimus limits polymorphonuclear leucocyte accumulation andprotects against myocardial ischaemia-reperfusion injury","volume":"32","author":"Squadrito","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199810150-00005","article-title":"Myocardial nuclear factor-\u03baB activity and nitric oxideproduction in rejecting cardiac allografts","volume":"66","author":"Cooper","year":"1998","journal-title":"Transplantation"},{"key":"B111","doi-asserted-by":"publisher","first-page":"L528","DOI":"10.1152\/ajplung.2000.279.3.L528","article-title":"Attenuation of lung reperfusion injury after transplantation usingan inhibitor of nuclear factor-\u03baB","volume":"279","author":"Ross","year":"2000","journal-title":"Am J Physiol - Lung Cell Mol Physiol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2014.909730","article-title":"Molecular Mechanism and Therapeutic Modulation of HMGB1 Release andAction: An Updated Review","volume":"10","author":"Lu","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-018-2930-9","article-title":"The Janus face of HMGB1 in heart disease: a necessaryupdate","volume":"76","author":"Raucci","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1097\/01.shk.0000209540.99176.72","article-title":"Elevated high-mobility group box 1 levels in patients with cerebraland myocardial ischemia","volume":"25","author":"Goldstein","year":"2006","journal-title":"Shock"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1007\/BF02172188","article-title":"A new puffing pattern induced by temperature shock and DNP indrosophila","volume":"18","author":"Ritossa","year":"1962","journal-title":"Experientia"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401417","article-title":"Functions of Heat Shock Proteins in Pathways of the Innate andAdaptive Immune System","volume":"193","author":"Binder","year":"2014","journal-title":"J Immunol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/nri2873-c1","article-title":"Heat shock proteins are no DAMPs, rather\u201cDAMPERs","volume":"11","author":"Broere","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1046\/j.1444-2892.2003.00139.x","article-title":"Myocardial heat shock protein changes in the failing heart followingcoronary artery ligation","volume":"12","author":"Tanonaka","year":"2003","journal-title":"Hear Lung Circ"},{"key":"B119","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1432-2277.1998.tb00782.x","article-title":"Expression of HSP 70 as a potential prognostic marker for acuterejection in human liver transplantation","volume":"11","author":"Floh\u00e9","year":"1998","journal-title":"Transpl Int"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1177\/43.2.7529785","article-title":"Expression of proteoglycans and hyaluronan during woundhealing","volume":"43","author":"Oksala","year":"1995","journal-title":"J Histochem Cytochem"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2013.05.021","article-title":"Hyaluronan production enhances shedding of plasma membrane-derivedmicrovesicles","volume":"319","author":"Rilla","year":"2013","journal-title":"Exp Cell Res"},{"key":"B122","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12929-014-0100-4","article-title":"Hyaluronan and cardiac regeneration","volume":"21","author":"Bonaf\u00e8","year":"2014","journal-title":"J Biomed Sci"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.5.2373","article-title":"Hyaluronan fragments activate an NF-kappa B\/I-kappa B alphaautoregulatory loop in murine macrophages","volume":"183","author":"Noble","year":"1996","journal-title":"J Exp Med"},{"key":"B124","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1476-9255-5-20","article-title":"Anti-oxidant inhibition of hyaluronan fragment-induced inflammatorygene expression","volume":"5","author":"Eberlein","year":"2008","journal-title":"J Inflammation"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-005-0144-6","article-title":"Extracellular matrix remodeling in canine and mouse myocardialinfarcts","volume":"324","author":"Dobaczewski","year":"2006","journal-title":"Cell Tissue Res"},{"key":"B126","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.3390\/ijms20163894","article-title":"High and low molecular weight hyaluronic acid differentiallyinfluences oxylipins synthesis in course of neuroinflammation","volume":"20","author":"Chistyakov","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2002.1193","article-title":"On the origin of mitochondria: A genomics perspective","volume":"358","author":"Andersson","year":"2003","journal-title":"2003"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/s0005-2728(98)00161-3","article-title":"The mitochondrial genome: Structure, transcription, translation andreplication","volume":"1410","author":"Taanman","year":"1999","journal-title":"Biochim Biophys Acta - Bioenergetics"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-020-06946-6","article-title":"The Role of Extracellular DNA and Histones in Ischaemia-ReperfusionInjury of the Myocardium","volume":"34","author":"Shah","year":"2020","journal-title":"Cardiovasc Drugs Ther"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190002","article-title":"Self-extracellular RNA acts in synergy with exogenous danger signalsto promote inflammation","volume":"12","author":"Noll","year":"2017","journal-title":"PloS One"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M310175200","article-title":"mRNA Is an Endogenous Ligand for Toll-like Receptor3","volume":"279","author":"Karik\u00f3","year":"2004","journal-title":"J Biol Chem"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20081370","article-title":"TLR3 is an endogenous sensor of tissue necrosis during acuteinflammatory events","volume":"205","author":"Cavassani","year":"2008","journal-title":"J Exp Med"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezu519","article-title":"RNase1 as a potential mediator of remote ischaemic preconditioningfor cardioprotection","volume":"48","author":"Cabrera-Fuentes","year":"2015","journal-title":"Eur J Cardio thoracic Surg"},{"key":"B134","article-title":"The Immune System","volume-title":"The ImmuneSystem","author":"Parham","year":"2009"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1038\/ncpcardio0938","article-title":"Mechanisms of disease: Toll-like receptors in cardiovasculardisease","volume":"4","author":"Frantz","year":"2007","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2011\/170352","article-title":"Toll-Like Receptors and Myocardial Inflammation","volume":"2011","author":"Feng","year":"2011","journal-title":"Int J Inflam"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000287597.87571.17","article-title":"Toll-like receptor 4 mediates the early inflammatory response aftercold ischemia\/reperfusion","volume":"84","author":"Kaczorowski","year":"2007","journal-title":"Transplantation"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000112575.66565.84","article-title":"Reduced Myocardial Ischemia-Reperfusion Injury in Toll-Like Receptor4-Deficient Mice","volume":"109","author":"Oyama","year":"2004","journal-title":"Circulation"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2003.11.036","article-title":"Toll-like receptor 4 mediates ischemia\/reperfusion injury of theheart","volume":"128","author":"Chong","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.107.158220","article-title":"Toll-like receptor 4 mediates maladaptive left ventricularremodeling and impairs cardiac function after myocardial infarction","volume":"102","author":"Timmers","year":"2008","journal-title":"CircRes"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-201007272-00497","article-title":"Cardiac allograft rejection correlates with increased expressions oftoll-like receptors 2 and 4 and allograft inflammatory factor 1","volume":"42","author":"McDaniel","year":"2010","journal-title":"Transplant Proc"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2010.06324.x","article-title":"Acute allograft rejection in human liver transplant recipients isassociated with signaling through toll-like receptor 4","volume":"26","author":"Testro","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1111\/iji.12446","article-title":"TLR-2, TLR-4 and MyD88 genes expression in renal transplant acuteand chronic rejections","volume":"46","author":"Sharbafi","year":"2019","journal-title":"Int J Immunogenet"},{"key":"B144","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.trim.2018.02.005","article-title":"Expression patterns of Toll like receptor (TLR)-2, TLR-4 and myeloiddifferentiation primary response gene 88 (MYD88) in renal transplant patients developing allograftdysfunction; a cohort study","volume":"48","author":"Hosseinzadeh","year":"2018","journal-title":"Transpl Immunol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2007.02.102","article-title":"The Role of Toll-Like Receptors 2 and 4 in Acute Allograft RejectionAfter Liver Transplantation","volume":"39","author":"Deng","year":"2007","journal-title":"Transplant Proc"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000101921.93016.1C","article-title":"Toll-Like Receptor-2 Modulates Ventricular Remodeling afterMyocardial Infarction","volume":"108","author":"Shishido","year":"2003","journal-title":"Circulation"},{"key":"B147","doi-asserted-by":"publisher","first-page":"H503","DOI":"10.1152\/ajpheart.00642.2006","article-title":"Toll-like receptor 2 modulates left ventricular function followingischemia-reperfusion injury","volume":"292","author":"Sakata","year":"2007","journal-title":"Am J Physiol - Hear Circ Physiol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cellimm.2019.02.005","article-title":"Toll-like receptor 2 deficiency promotes the generation ofalloreactive Th17 cells after cardiac transplantation in mice","volume":"338","author":"Li","year":"2019","journal-title":"CellImmunol"},{"key":"B149","unstructured":"NCT01794663Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft Function2013"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvz057","article-title":"Toll-like receptor 7 deficiency promotes survival and reducesadverse left ventricular remodelling after myocardial infarction","volume":"115","author":"De Kleijn","year":"2019","journal-title":"Cardiovasc Res"},{"key":"B151","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bbadis.2013.10.006","article-title":"Toll-like receptor 3 plays a role in myocardial infarction andischemia\/reperfusion injury","volume":"1842","author":"Lu","year":"2014","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012687","article-title":"Bacterial flagellin triggers cardiac innate immune responses andacute contractile dysfunction","volume":"5","author":"Rolli","year":"2010","journal-title":"PloS One"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1042\/CS20140444","article-title":"Toll-like receptor 5 deficiency exacerbates cardiac injury andinflammation induced by myocardial ischaemia-reperfusion in the mouse","volume":"129","author":"Parapanov","year":"2015","journal-title":"ClinSci"},{"key":"B154","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.abb.2019.02.008","article-title":"NOD-like receptors and inflammasomes: A review of their canonicaland non-canonical signaling pathways","volume":"670","author":"Platnich","year":"2019","journal-title":"Arch Biochem Biophysics"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000000717","article-title":"NLRP3 Inflammasome in Acute Myocardial Infarction","volume":"74","author":"Mauro","year":"2019","journal-title":"J Cardiovasc Pharmacol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2017.161","article-title":"The NLRP3 inflammasome in acute myocardial infarction","volume":"15","author":"Toldo","year":"2018","journal-title":"Nat Rev Cardiol [Internet]"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1172\/JCI93537","article-title":"Inflammasomes and IL-1 biology in the pathogenesis of allograftdysfunction","volume":"127","author":"Weigt","year":"2017","journal-title":"J Clin Invest"},{"key":"B158","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/CIRCULATIONAHA.110.982777","article-title":"Inflammasome Activation of Cardiac Fibroblasts Is Essential for Myocardial Ischemia\/Reperfusion Injury","volume":"123","author":"Kawaguchi","year":"2011","journal-title":"Circulation"},{"key":"B159","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/3480637","article-title":"Maladaptive modulations of nlrp3 inflammasome and cardioprotectivepathways are involved in diet-induced exacerbation of myocardial ischemia\/reperfusion injury inmice","volume":"2016","author":"Mastrocola","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2009.09.008","article-title":"Upregulation of the apoptosis-related inflammasome in cardiacallograft rejection","volume":"29","author":"Seto","year":"2010","journal-title":"J Hear Lung Transplant"},{"key":"B161","first-page":"A10771","article-title":"Modulation of inflammasome mediated ischemia and reperfusion injuryin donation after circulatory death heart","volume":"138","author":"Quader","year":"2018","journal-title":"Circulation"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30065-5","article-title":"Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, fortreatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2atrial","volume":"2","author":"Kl\u00fcck","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000000696","article-title":"NLRP3 Inflammasome in Cardioprotective Signaling","volume":"74","author":"Zuurbier","year":"2019","journal-title":"J Cardiovasc Pharmacol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.09.148","article-title":"Nlrp3 plays no role in acute cardiac infarction due to low cardiac expression","volume":"177","author":"Jong","year":"2014","journal-title":"Int J Cardiol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2015.12.051","article-title":"NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective","volume":"469","author":"Sandanger","year":"2016","journal-title":"Biochem Biophys Res Commun [Internet]"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040643","article-title":"Deletion of the innate immune NLRP3 receptor abolishes cardiacischemic preconditioning and is associated with decreased IL-6\/STAT3 signaling","volume":"7","author":"Zuurbier","year":"2012","journal-title":"PloS One"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1038\/nature04515","article-title":"Cryopyrin activates the inflammasome in response to toxins andATP","volume":"440","author":"Mariathasan","year":"2006","journal-title":"Nature"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000514","article-title":"Safety and Efficacy of an Oral Inhibitor of the Purinergic ReceptorP2X7 in Adult Patients with Moderately to Severely Active Crohn\u2019s Disease: A RandomizedPlacebo-controlled, Double-blind, Phase IIa Study","volume":"21","author":"Eser","year":"2015","journal-title":"Inflammation Bowel Dis"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110874","article-title":"Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor,in treatment of patients with rheumatoid arthritis inadequately controlled bymethotrexate","volume":"39","author":"Stock","year":"2012","journal-title":"J Rheumatol"},{"key":"B170","volume-title":"First Time in Human Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and the Effect of Food of Single Assending Doses of GSK1482160","year":"2008"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-019-0502-9","article-title":"Targeting neuroinflammation with brain penetrant P2X7 antagonists asnovel therapeutics for neuropsychiatric disorders","volume":"45","author":"Bhattacharya","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"B172","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(18)42137-0","article-title":"Isolation and characterization of two binding proteins for advancedglycosylation end products from bovine lung which are present on the endothelial cellsurface","volume":"267","author":"Schmidt","year":"1992","journal-title":"J Biol Chem"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.575993","article-title":"Receptor for advanced-glycation end products: Key modulator ofmyocardial ischemic injury","volume":"113","author":"Bucciarelli","year":"2006","journal-title":"Circulation"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.2217\/bmm.14.113","article-title":"Advanced glycation end-products as long-term predictors of death andreinfarction after an acute coronary syndrome","volume":"9","author":"Raposeiras-Roub\u00edn","year":"2015","journal-title":"Biomark Med"},{"key":"B175","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1475-2840-11-102","article-title":"Predictive value of advanced glycation end products for thedevelopment of post-infarction heart failure: a preliminary report","volume":"11","author":"Raposeiras-Roub\u00edn","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209964","article-title":"Characterization of advanced glycation end products and theirreceptor (RAGE) in an animal model of myocardial infarction","volume":"14","author":"de Moraes Fracasso","year":"2019","journal-title":"PloS One"},{"key":"B177","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1600-6143.2006.01617.x","article-title":"Blockade of RAGE suppresses alloimmune reactions in vitro and delaysallograft rejection in murine heart transplantation","volume":"7","author":"Moser","year":"2007","journal-title":"Am J Transplant"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1016\/S1665-2681(19)30781-1","article-title":"Involvement of the receptor for advanced glycation end products inliver transplantation","volume":"14","author":"Navarra","year":"2015","journal-title":"Ann Hepatol"},{"key":"B179","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/501430","article-title":"Reactive metabolites and AGE-RAGE-mediated inflammation in patientsfollowing liver transplantation","volume":"2013","author":"Brenner","year":"2013","journal-title":"Mediators Inflammation"},{"key":"B180","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"B181","first-page":"77","article-title":"Inhibition of nuclear factor kappa B pathway protects myocardialischemia\/reperfusion injury in rats under treatment with abnormal savda munziq","volume":"10","author":"Maimaitiaili","year":"2018","journal-title":"Am J Transl Res"},{"key":"B182","doi-asserted-by":"publisher","first-page":"H1089","DOI":"10.1152\/ajpheart.00067.2013","article-title":"Cardiomyocyte-specific p65 NF-\u03baB deletion protects the injuredheart by preservation of calcium handling","volume":"305","author":"Zhang","year":"2013","journal-title":"Am J Physiol - Hear Circ Physiol"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1097\/01.LAB.0000082060.39079.A6","article-title":"Gene transfer of I\u03baB\u03b1 limits infarct size in a mousemodel of myocardial ischemia-reperfusion injury","volume":"83","author":"Squadrito","year":"2003","journal-title":"Lab Invest"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1097\/00024382-200202000-00008","article-title":"Sesquiterpene lactone parthenolide, an inhibitor of I\u03baB kinasecomplex and nuclear factor-\u03baB, exerts beneficial effects in myocardial reperfusioninjury","volume":"17","author":"Zingarelli","year":"2002","journal-title":"Shock"},{"key":"B185","doi-asserted-by":"publisher","first-page":"H919","DOI":"10.1152\/ajpheart.00851.2002","article-title":"Proteasome inhibition ablates activation of NF-\u03baB inmyocardial reperfusion and reduces reperfusion injury","volume":"284","author":"Pye","year":"2003","journal-title":"Am J Physiol - HearCirc Physiol"},{"key":"B186","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.trre.2011.07.005","article-title":"Role of T cell-nuclear factor \u03baB intransplantation","volume":"26","author":"Molinero","year":"2012","journal-title":"Transplant Rev"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200104150-00003","article-title":"Differential NF-\u03baB and I\u03baB gene expression duringdevelopment of cardiac allograft rejection versus CD154 monoclonal antibody-inducedtolerance","volume":"71","author":"Csizmadia","year":"2001","journal-title":"Transplantation"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4428","article-title":"IRF3 and type i interferons fuel a fatal response to myocardialinfarction","volume":"23","author":"King","year":"2017","journal-title":"Nat Med"},{"key":"B189","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00395-018-0709-7","article-title":"Elevated monocyte-specific type I interferon signalling correlatespositively with cardiac healing in myocardial infarct patients but interferon alpha application deteriorates myocardial healing in rats","volume":"114","author":"ter Horst","year":"2019","journal-title":"Basic Res Cardiol"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.305462","article-title":"The NHLBI-Sponsored Consortium for preclinicAl assESsment of cARdioprotective Therapies (CAESAR)","volume":"116","author":"Jones","year":"2015","journal-title":"Circ Res [Internet]"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.311565","article-title":"Translational research in cardiovascular repair a call for aparadigm shift","volume":"122","author":"Chamuleau","year":"2018","journal-title":"Circ Res"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa155","article-title":"Improving translational research in sex-specific effects ofcomorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper andrecommendations of the ESC Working Group on Cellular Biology of the Heart","volume":"2","author":"Perrino","year":"2020","journal-title":"Cardiovasc Res"},{"key":"B193","doi-asserted-by":"publisher","first-page":"14218","DOI":"10.1038\/s41598-017-14294-z","article-title":"Optimization of large animal MI models; A systematic analysis ofcontrol groups from preclinical studies","volume":"7","author":"Zwetsloot","year":"2017","journal-title":"Sci Rep"},{"key":"B194","doi-asserted-by":"publisher","first-page":"H821","DOI":"10.1152\/ajpheart.00335.2017","article-title":"Guidelines for experimental models of myocardial ischemia andinfarction","volume":"314","author":"Lindsey","year":"2018","journal-title":"Am J Physiol - Heart Circulatory Physiol"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12656","article-title":"Invasive surgery reduces infarct size and preserves cardiac functionin a porcine model of myocardial infarction","volume":"19","author":"van Hout","year":"2015","journal-title":"J Cell Mol Med"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvv239","article-title":"Translational failure of anti-inflammatory compounds for myocardialinfarction: A meta-Analysis of large animal models","volume":"109","author":"Van Hout","year":"2016","journal-title":"Cardiovasc Res"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1080\/17434440.2018.1430568","article-title":"Devices for ex vivo heart and lung perfusion","volume":"15","author":"Schraufnagel","year":"2018","journal-title":"Expert Rev Med Devices"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006552","article-title":"Immunity and Stress Responses Are Induced During Ex Situ HeartPerfusion","volume":"13","author":"Hatami","year":"2020","journal-title":"Circ Hear Fail"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2006.09.019","article-title":"The effect of ischemic time on survival after heart transplantationvaries by donor age: An analysis of the United Network for Organ Sharing database","volume":"133","author":"Russo","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvy304","article-title":"Innate immunity as a target for acutecardioprotection","volume":"115","author":"Zuurbier","year":"2019","journal-title":"Cardiovasc Res"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nat [Internet]"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2018.08.014","article-title":"Effect of statins on toll-like receptors: a new insight topleiotropic effects","volume":"135","author":"Bahrami","year":"2018","journal-title":"Pharmacol Res"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2014.28","article-title":"The inflammatory response in myocardial injury, repair, andremodelling","volume":"11","author":"Frangogiannis","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"B204","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41418-019-0374-x","article-title":"Deletion of heat shock protein 60 in adult mouse cardiomyocytesperturbs mitochondrial protein homeostasis and causes heart failure","volume":"27","author":"Fan","year":"2020","journal-title":"Cell Death Differ"},{"key":"B205","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jacc.2018.09.086","article-title":"Multitarget Strategies to Reduce Myocardial Ischemia\/ReperfusionInjury: JACC Review Topic of the Week","volume":"73","author":"Davidson","year":"2019","journal-title":"J Am Coll Cardiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.599511\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T15:22:39Z","timestamp":1697296959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.599511\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,8]]},"references-count":205,"alternative-id":["10.3389\/fimmu.2020.599511"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.599511","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,8]]},"article-number":"599511"}}